FDA Inspection 1072736 — Lee Pharma Ltd.

Lee Pharma Ltd. — FEI 3009103626

The FDA completed an inspection of Lee Pharma Ltd. on November 2, 2018 in Hyderabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 2, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hyderabad (India)